Medical management options for heavy menstrual bleeding, as recommended by NICE, include: Levonorgestrel intrauterine system (LNG-IUS) : Often first-line treatment, reducing menstrual blood loss by up to 95% within 12 months Tranexamic acid : An antifibrinolytic agent taken during menstruation to reduce blood loss by 40-50% (caution if you have a history of blood clots) Non-steroidal anti-inflammatory drugs (NSAIDs) : Such as mefenamic acid, which can reduce flow by 20-30% and help with associated pain (use with caution if you have gastrointestinal, renal or cardiovascular conditions) Combined hormonal contraception : Can regulate cycles and reduce bleeding in suitable candidates Oral progestogens : Taken cyclically or continuously, depending on individual circumstances If you currently use a copper intrauterine device (IUD), this can contribute to heavier periods, and switching to a levonorgestrel IUS might be beneficial
Other benefits of the medication include improved energy levels, better sleep quality, and a reduced risk of obesity-related health problems
Written informed consent was approved by the IRB and signed by all participants before enrollment
Why State Rules and Medical Board Guidance Still Matter FDA status is just one part of compliance
For patients with diabetes, managing blood glucose is crucial to preventing diabetic nephropathy, which is characterized by kidney damage due to prolonged high blood sugar
Combining it with the right habits can enhance its effectiveness in improving skin tone and radiance
